255 related articles for article (PubMed ID: 20406299)
1. The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1).
Woodward EA; Prêle CM; Nicholson SE; Kolesnik TB; Hart PH
Immunology; 2010 Sep; 131(1):118-27. PubMed ID: 20406299
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages.
Prêle CM; Woodward EA; Bisley J; Keith-Magee A; Nicholson SE; Hart PH
J Immunol; 2008 Dec; 181(11):8018-26. PubMed ID: 19017994
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signalling-3 at pathological levels does not regulate lipopolysaccharide or interleukin-10 control of tumour necrosis factor-alpha production by human monocytes.
Prêle CM; Keith-Magee AL; Yerkovich ST; Murcha M; Hart PH
Immunology; 2006 Sep; 119(1):8-17. PubMed ID: 16925527
[TBL] [Abstract][Full Text] [Related]
4. Muramyldipeptide augments the actions of lipopolysaccharide in mice by stimulating macrophages to produce pro-IL-1β and by down-regulation of the suppressor of cytokine signaling 1 (SOCS1).
Shikama Y; Kuroishi T; Nagai Y; Iwakura Y; Shimauchi H; Takada H; Sugawara S; Endo Y
Innate Immun; 2011 Feb; 17(1):3-15. PubMed ID: 19897531
[TBL] [Abstract][Full Text] [Related]
5. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
[TBL] [Abstract][Full Text] [Related]
6. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
7. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
[TBL] [Abstract][Full Text] [Related]
8. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.
Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T
Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589
[TBL] [Abstract][Full Text] [Related]
9. Cytokine regulation of TNF-alpha mRNA and protein production by unprimed macrophages from C57Bl/6 and NZW mice.
Schook LB; Albrecht H; Gallay P; Jongeneel CV
J Leukoc Biol; 1994 Oct; 56(4):514-20. PubMed ID: 7930949
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.
Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A
Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
de Waal Malefyt R; Abrams J; Bennett B; Figdor CG; de Vries JE
J Exp Med; 1991 Nov; 174(5):1209-20. PubMed ID: 1940799
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling 1 protects rat pancreatic islets from cytokine-induced apoptosis through Janus kinase/signal transducers and activators of transcription pathway.
Sun Q; Xiang RL; Yang YL; Feng K; Zhang K; Ding WY
Chin Med J (Engl); 2013 Nov; 126(21):4048-53. PubMed ID: 24229672
[TBL] [Abstract][Full Text] [Related]
13. Diphlorethohydroxycarmalol inhibits interleukin-6 production by regulating NF-κB, STAT5 and SOCS1 in lipopolysaccharide-stimulated RAW264.7 cells.
Kang NJ; Han SC; Kang GJ; Koo DH; Koh YS; Hyun JW; Lee NH; Ko MH; Kang HK; Yoo ES
Mar Drugs; 2015 Apr; 13(4):2141-57. PubMed ID: 25871292
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function.
Whyte CS; Bishop ET; Rückerl D; Gaspar-Pereira S; Barker RN; Allen JE; Rees AJ; Wilson HM
J Leukoc Biol; 2011 Nov; 90(5):845-54. PubMed ID: 21628332
[TBL] [Abstract][Full Text] [Related]
15. Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10.
Hart PH; Jones CA; Finlay-Jones JJ
J Leukoc Biol; 1995 Jun; 57(6):909-18. PubMed ID: 7540642
[TBL] [Abstract][Full Text] [Related]
16. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
Wanidworanun C; Strober W
J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4.
Park SJ; Lee KP; Kang S; Lee J; Sato K; Chung HY; Okajima F; Im DS
Cell Signal; 2014 Oct; 26(10):2249-58. PubMed ID: 25035231
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes.
Hayes MP; Wang J; Norcross MA
Blood; 1995 Jul; 86(2):646-50. PubMed ID: 7605994
[TBL] [Abstract][Full Text] [Related]
19. [Triptolide inhibits the inflammatory response of monocytes from rheumatoid arthritis patients by regulating miR-155].
Peng A; Huang X; Liu R; Wang X; Zhuang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):635-8. PubMed ID: 24909288
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production.
Bonder CS; Dickensheets HL; Finlay-Jones JJ; Donnelly RP; Hart PH
J Immunol; 1998 Apr; 160(8):4048-56. PubMed ID: 9558115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
